Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Clinical and regulatory support services / Clinical evidence and trial services / Pharma and biotech outsourced clinical development

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Pharma and biotech outsourced clinical development

Pharmaceutical and biotechnology companies that outsource protocol design, patient and site management, monitoring, data management and regulatory-submission evidence across the clinical development lifecycle, including evidence work used for payer coverage.

Market size
$63.6B
$63.6B ($62.6B–$64.7B) · 2025 · Top-down
Growth
—
CAGR
Attractiveness
— /100
for B2B sellers
Evidence
Medium confidence
1 source · Top-down
Level
Niche
Segmented by
Customer type
Buyers
Pharmaceutical and biotechnology sponsors
Buying centre
Clinical development, regulatory affairs, HEOR/market access, procurement
Buying triggers
  • New clinical programme or protocol launch
  • Phase transition or pivotal-study start
  • Regulatory-submission deadline
  • Payer-coverage evidence request
Pains
  • Slow patient recruitment and site activation
  • Fragmented trial operations and data handoffs
  • Incomplete or submission-inconsistent evidence packages
  • Insufficient internal capacity to run concurrent studies
Scores (1–5)
Pain intensity—
Purchasing power—
Reachability—
Growth—

How this was sized

$63.6B ($62.6B–$64.7B) · 2025 · Top-down

Annual vendor revenue is estimated as published CRO/clinical-trial services of $57.5-$59.6B plus published medical-writing services of $5.1B, giving $62.6-$64.7B for 2025. The source reports 6.5%-7.5% annual growth for CRO/clinical-trial services and about 10% for medical writing, but no consistent combined forecast horizon; therefore no combined forecast or CAGR is stated. The total covers outsourced clinical development and submission-document services, not the full internal cost of trials.

Alongside it in Clinical evidence and trial services

// Sell into Pharma and biotech outsourced clinical development

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.